Key Findings:  This rat model of inflammatory bowel disease (IBD) found that tetrahydrocannabinol (THC) exacerbates the negative behavioral effects of IBD
Type of Study:  Animal Study
Study Result:  Negative
Research Location(s):  United States
Year of Pub:  2021
Cannabinoids Studied:  Tetrahydrocannabinol (THC)
Phytocannabinoid Source:  Unspecified
Chemotype:  Chemotype I
Dosage: THC (0.32 mg/kg)
Route of Administration:  Injection
Citation:  Dunford J, et al. Tetrahydrocannabinol (THC) Exacerbates Inflammatory Bowel Disease in Adolescent and Adult Female Rats. J Pain. 2021; 22:1040-1047. doi: 10.1016/j.jpain.2021.02.014
Authors:  Dunford J, Lee AT, Morgan MM